Clinical Trial Update: Cefar URO - Symptomatic Treatment of Overactive Bladder [NA]

View source ↗

Summary

This clinical trial entry describes Cefar URO as a symptomatic treatment for overactive bladder, with the study status listed as not yet recruiting and sponsore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Cefar URO

Snippet

Sponsor: DJO UK Ltd | Conditions: Overactive Bladder (OAB), Refractory Overactive Bladder | NA | Status: NOT_YET_RECRUITING